|
|
Volumn 16, Issue 1, 2010, Pages 18-21
|
|
The saving switch
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AROMATASE INHIBITOR;
AZACITIDINE;
DIMETHYL SULFOXIDE;
DNA;
ENTINOSTAT;
HEMOGLOBIN;
HISTONE DEACETYLASE INHIBITOR;
ROMIDEPSIN;
TAMOXIFEN;
UNCLASSIFIED DRUG;
VORINOSTAT;
BONE MARROW DISEASE;
CANCER CELL;
CANCER RESEARCH;
CHROMATIN;
CUTANEOUS T CELL LYMPHOMA;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG SAFETY;
EPIGENETICS;
FOOD AND DRUG ADMINISTRATION;
GENE ACTIVITY;
GENE SWITCHING;
GENOME;
HUMAN;
MYELODYSPASTIC SYNDROME;
NOTE;
PRIORITY JOURNAL;
SCIENTIST;
SICKLE CELL ANEMIA;
TUMOR VOLUME;
ANIMALS;
ANTINEOPLASTIC AGENTS;
EPIGENESIS, GENETIC;
GENES, SWITCH;
HISTONE DEACETYLASE INHIBITORS;
HISTONE DEACETYLASES;
HUMANS;
HYDROXAMIC ACIDS;
MICE;
NEOPLASMS, EXPERIMENTAL;
|
|
EID: 73849125358
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm0110-18 Document Type: Note |
|
Times cited : (10)
|
|
References (0)
|